T. Rowe Price Group

T. Rowe Price Group, Inc. is a publicly owned investment management firm founded in 1937 and headquartered in Baltimore, Maryland. The company offers a diverse range of services, including separate account management, mutual funds, and sub-advisory services, catering to individuals, institutional investors, retirement plans, and financial intermediaries. T. Rowe Price manages investments in both public equity and fixed income markets globally, employing a combination of fundamental and quantitative analysis with a bottom-up investment approach. The firm also engages in socially responsible investing, focusing on environmental, social, and governance issues. In addition to traditional investment strategies, T. Rowe Price participates in late-stage venture capital investments, typically investing between $3 million and $5 million. The company operates numerous offices worldwide, reinforcing its commitment to delivering investment excellence over the long term.

Ziad Bakri

Vice President

Oliver Bell

Associate Head of International Equities, Portfolio Manager, Member of the International Equity Steering Committee and Board Member of T. Rowe Price (Luxembourg) Management

Eiswert C.F.A., CFA, David J.

Vice President and Portfolio Manager

Jennifer St. Germain

Vice President

John Hall

Investment Analyst

Kenneth Moreland

CFO and Treasurer

Julio Novo

Investor

Anthony Wang

Portfolio Manager - Vice President T. Rowe Price Group

Jeff Zoller

Vice President

Past deals in British Columbia

Jetti Resources

Series C in 2021
Jetti Resources is a Canadian company founded in 2014, headquartered in Vancouver, specializing in the development of hydrometallurgical technology for metal extraction from mineral ores. The company focuses on extracting copper from low-grade primary sulfides, particularly chalcopyrite, the most abundant copper mineral ore. Jetti's proprietary catalytic technology effectively addresses the challenges associated with recovering vast amounts of trapped resources, significantly enhancing copper yields while being cost-effective and environmentally responsible. In addition to copper, the technology can also be applied to the extraction of zinc and nickel from sulfide ores, contributing to more efficient mineral processing practices.

Clio

Series E in 2021
Themis Solutions Inc. develops legal practice management and client intake software solutions for law firms. The company’s platforms are used for billing, case management, contact management, document management, calendaring, online payments, and time and expense tracking. The company was founded in 2007 and is based in Burnaby, Canada with additional offices in Toronto, Calgary, Canada; Santa Monica, California; and Dublin, Ireland.

Kardium

Private Equity Round in 2021
Kardium Inc. is a medical solutions company based in Burnaby, Canada, specializing in the diagnosis and treatment of atrial fibrillation (AF). Founded in 2007, the company has developed the Globe Mapping and Ablation System, which streamlines AF treatment by integrating single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation into a single catheter. This advanced system aids medical practitioners in diagnosing and treating cardiovascular diseases by providing detailed electrophysiological mapping and the ability to ablate cardiac tissue using radio-frequency energy. Kardium's team comprises experts in medicine, engineering, and research, ensuring a robust foundation for innovation in medical device technology.

Kardium

Private Equity Round in 2019
Kardium Inc. is a medical solutions company based in Burnaby, Canada, specializing in the diagnosis and treatment of atrial fibrillation (AF). Founded in 2007, the company has developed the Globe Mapping and Ablation System, which streamlines AF treatment by integrating single-shot pulmonary vein isolation, high-definition mapping, and atrial ablation into a single catheter. This advanced system aids medical practitioners in diagnosing and treating cardiovascular diseases by providing detailed electrophysiological mapping and the ability to ablate cardiac tissue using radio-frequency energy. Kardium's team comprises experts in medicine, engineering, and research, ensuring a robust foundation for innovation in medical device technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.